Literature DB >> 8912485

Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease.

Y Stern1, X Liu, M Albert, J Brandt, D M Jacobs, C Del Castillo-Castaneda, K Marder, K Bell, M Sano, F Bylsma.   

Abstract

OBJECTIVE: To determine how the advent of extrapyramidal signs influences the progression of Alzheimer disease as measured by standard clinical measures.
DESIGN: We applied growth curve models to prospective data to characterize patients' cognitive and functional changes over time. To detect changes in disease course related to extrapyramidal signs, their onset was treated as a time-dependent covariate.
SETTING: Three research medical centers. PARTICIPANTS: Patients (n = 217) with probable Alzheimer disease. INTERVENTION: Patients were followed up semiannually for 5 years. MAIN OUTCOME MEASURES: Scores on the modified Mini-Mental State Examination and measures of basic and instrumental activities of daily living from the Blessed Dementia Rating Scale.
RESULTS: For basic and instrumental activities of daily living, disease course was more rapid once extrapyramidal signs developed. Decline in the modified Mini-Mental State Examination score was greater at the time the signs developed, but not at subsequent visits.
CONCLUSIONS: The point at which extrapyramidal signs emerge is associated with measurable acceleration in the progression of Alzheimer disease. This may in part explain why extrapyramidal signs are associated with a poorer prognosis. The differential influence of extrapyramidal signs on cognitive and functional measures suggests that the pathological changes underlying these disease features may vary.

Entities:  

Mesh:

Year:  1996        PMID: 8912485     DOI: 10.1001/archneur.1996.00550110061013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study.

Authors:  Florence Portet; Nikolaos Scarmeas; Stephanie Cosentino; Elisabeth P Helzner; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-09

Review 2.  Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment.

Authors:  Abhilash K Desai; George T Grossberg; Dharmesh N Sheth
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

3.  Education and rates of cognitive decline in incident Alzheimer's disease.

Authors:  N Scarmeas; S M Albert; J J Manly; Y Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

4.  Coupled cognitive and functional change in Alzheimer's disease and the influence of depressive symptoms.

Authors:  Laura B Zahodne; D P Devanand; Yaakov Stern
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  The Predictors study: Development and baseline characteristics of the Predictors 3 cohort.

Authors:  Yaakov Stern; Yian Gu; Stephanie Cosentino; Martina Azar; Siobhan Lawless; Oksana Tatarina
Journal:  Alzheimers Dement       Date:  2016-05-21       Impact factor: 21.566

6.  Medicare claims analysis of agents used to manage dementia-related psychosis: a treatment pattern study.

Authors:  Nazia Rashid; James B Wetmore; Muna Irfan; Yi Peng; Victor Abler
Journal:  Int Clin Psychopharmacol       Date:  2022-05-01       Impact factor: 1.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.